BMY Bristol-Myers Squibb Company
Healthcare$59.46-0.15%ClosedMarket Cap: $121.42B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$62.00
Target (Median)
$60.00
Target Range
$40.00 - $75.00
Upside from current price: 4.3%
Rating Distribution
4 Strong Buy6 Buy18 Hold1 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-09 | B of A Securities | maintain | Buy | Buy |
| 2026-04-08 | Guggenheim | maintain | Buy | Buy |
| 2026-04-08 | Cantor Fitzgerald | maintain | Neutral | Neutral |
| 2026-03-17 | HSBC | maintain | Hold | Hold |
| 2026-02-23 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-02-06 | Guggenheim | maintain | Buy | Buy |
| 2026-02-06 | Citigroup | maintain | Neutral | Neutral |
| 2026-02-06 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| 2026-01-13 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-01-09 | Scotiabank | maintain | Sector Perform | Sector Perform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $6.15 | $46.27B | 17 |
| Sun Dec 31 | $5.39 | $40.95B | 9 |
| Mon Dec 31 | $4.88 | $37.37B | 3 |
| Tue Dec 31 | $4.85 | $36.63B | 3 |